menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Pathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

Why is biomarker testing more important than ever to help inform care in gastric cancer patients? And should it be discussed earlier in the course of treatment?

  • Brought to you by

  • Overview

    Gastric cancer and GEJ cancer are difficult-to-treat malignancies, and established and emerging biomarkers can expand views of previously unidentified patient subsets and may inform clinical decisions. How can pathologists and oncologists work together to deliver biomarker-driven personalized care for gastric and GEJ cancer patients? To learn more, join Dr. Turck who speaks with Dr. Nataliya Uboha, Associate Professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, and Dr. Kristina Matkowskyj, Professor in the Department of Pathology and Laboratory Medicine at the University of Wisconsin School of Medicine and Public Health.

     

    074-0910-PM 8/23 

     

Schedule19 Apr 2024